Therefore, we focused on GYS1 protein expression and its association with glycogen content and clinicopathological characteristics in a tissue microarray (TMA) constructed with tissue from human breast tumors obtained during primary surgery (Suppl. This evidence concerns the gene GYS1 and breast neoplasm.